Zhaokai Zhou

发表

Ferroptosis and EMT: key targets for combating cancer progression and therapy resistance

Siyuan Weng, Guojun Zhang, Hui-Xian Xu, 2023, Cellular and Molecular Life Sciences.

Omics-based molecular classifications empowering in precision oncology.

Siyuan Weng, Zaoqu Liu, Xinwei Han, 2024, Cellular oncology.

Crosstalk between regulated cell death and immunity in redox dyshomeostasis for pancreatic cancer.

J. Li, Shuai-Xi Yang, Jianguo Wen, 2023, Cellular signalling.

Immunosuppression in tumor immune microenvironment and its optimization from CAR-T cell therapy

Qin Dang, Hui-Xian Xu, Zaoqu Liu, 2022, Theranostics.

Epigenetically regulated gene expression profiles decipher four molecular subtypes with prognostic and therapeutic implications in gastric cancer

Jinhai Deng, Siyuan Weng, Hui-Xian Xu, 2023, Clinical Epigenetics.

Biological and pharmacological roles of m6A modifications in cancer drug resistance

Qin Dang, Hui-Xian Xu, Zaoqu Liu, 2022, Molecular cancer.

Engineering neoantigen vaccines to improve cancer personalized immunotherapy

Huanyu Li, Y. Kong, Qin Dang, 2022, International journal of biological sciences.

Proteomics appending a complementary dimension to precision oncotherapy.

Siyuan Weng, Zaoqu Liu, Xinwei Han, 2024, Computational and structural biotechnology journal.

Non-targeted metabolomics revealed novel links between serum metabolites and primary ovarian insufficiency: a Mendelian randomization study

Zhaokai Zhou, Shuang Chen, Shuang Chen, 2024, Frontiers in endocrinology.

Smooth muscle cell fate decisions decipher a high-resolution heterogeneity within atherosclerosis molecular subtypes

Tao-Sheng Li, Yunzhe Wang, Jiacheng Guo, 2022, Journal of Translational Medicine.

Molecular subtypes of colorectal cancer in the era of precision oncotherapy: Current inspirations and future challenges

Siyuan Weng, Hui-Xian Xu, Zaoqu Liu, 2024, Cancer medicine.

Emerging role of immunogenic cell death in cancer immunotherapy: Advancing next-generation CAR-T cell immunotherapy by combination.

Yumiao Mai, Zhaokai Zhou, Bo Han, 2024, Cancer letters.

Infiltrating treg reprogramming in the tumor immune microenvironment and its optimization for immunotherapy

Siyuan Weng, Hui-Xian Xu, Zaoqu Liu, 2024, Biomarker research.

A metabolome-wide Mendelian randomization study prioritizes causal circulating metabolites for reproductive disorders including primary ovarian insufficiency, polycystic ovary syndrome, and abnormal spermatozoa

Zhaokai Zhou, Shuang Chen, Zihan Zhou, 2024, Journal of ovarian research.

Deciphering the tumor immune microenvironment from a multidimensional omics perspective: insight into next-generation CAR-T cell immunotherapy and beyond

Zhan Wang, Run Shi, Zhaokai Zhou, 2024, Molecular cancer.

Deciphering the prognostic role of endoplasmic reticulum stress in lung adenocarcinoma: integrating prognostic prediction and immunotherapy strategies

Lianmin Zhang, Zhenfa Zhang, Zhaokai Zhou, 2024, Clinical and experimental medicine.

Molecular subtypes of ischemic heart disease based on circadian rhythm

Xinwei Han, Yudi Xu, Zhan Wang, 2024, Scientific Reports.

The underlying mechanism of chimeric antigen receptor (CAR)-T cell therapy triggering secondary T-cell cancers: mystery of the Sphinx?

Zhaokai Zhou, Ge Zhang, Yudi Xu, 2024, Cancer letters.

Multifaceted role of redox pattern in the tumor immune microenvironment regarding autophagy and apoptosis

Q. Cheng, P. Luo, Siyuan Weng, 2023, Molecular Cancer.

Integration of proteomics and transcriptomics to construct a prognostic signature of renal clear cell carcinoma

Chuanchuan Ren, Z. Ye, Zhaokai Zhou, 2024, International journal of medical sciences.

Circadian disruption in cancer hallmarks: novel insight into the molecular mechanisms of tumorigenesis and cancer treatment.

Siyuan Weng, Hui-Xian Xu, Zaoqu Liu, 2024, Cancer letters.

An assessment system for clinical and biological interpretability in ulcerative colitis

Fuqi Wang, Wenming Cui, Zhaokai Zhou, 2024, Aging.